New Zealand markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4250-0.0450 (-3.06%)
As of 11:31AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 393.89M
Enterprise value 696.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.86
Price/book (mrq)0.56
Enterprise value/revenue 3.47
Enterprise value/EBITDA -2.51

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-85.26%
S&P500 52-week change 325.01%
52-week high 314.5500
52-week low 31.2500
50-day moving average 34.0240
200-day moving average 37.9392

Share statistics

Avg vol (3-month) 39.77M
Avg vol (10-day) 318.62M
Shares outstanding 5267.95M
Implied shares outstanding 6267.95M
Float 8266.46M
% held by insiders 12.80%
% held by institutions 1101.26%
Shares short (28 Mar 2024) 449.05M
Short ratio (28 Mar 2024) 45.76
Short % of float (28 Mar 2024) 420.29%
Short % of shares outstanding (28 Mar 2024) 418.31%
Shares short (prior month 29 Feb 2024) 443.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -152.97%
Operating margin (ttm)-142.14%

Management effectiveness

Return on assets (ttm)-10.92%
Return on equity (ttm)-48.53%

Income statement

Revenue (ttm)200.52M
Revenue per share (ttm)0.79
Quarterly revenue growth (yoy)113.30%
Gross profit (ttm)N/A
EBITDA -287.2M
Net income avi to common (ttm)-306.74M
Diluted EPS (ttm)-1.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)634.42M
Total cash per share (mrq)2.37
Total debt (mrq)933.93M
Total debt/equity (mrq)133.17%
Current ratio (mrq)7.81
Book value per share (mrq)2.62

Cash flow statement

Operating cash flow (ttm)-259.17M
Levered free cash flow (ttm)-306.52M